Release Date: 06/04/18 09:37 Summary: Response to ASX Price Query Price Sensitive: Yes Download Document 286.06KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%